Hitachi And Redlen Technologies Announce Agreement On Joint Development
March 7, 2016
Saanichton, BC, — Hitachi Medical Corporation, a subsidiary of Hitachi, Ltd. (TSE:6501) and Redlen Technologies Inc., a Canadian technology company, today announced an agreement to jointly develop a direct conversion semiconductor x-ray detector module required for new photon counting computed tomography systems (PCCT), a promising next generation diagnostic medical imaging modality.
Hitachi has been focusing on the healthcare field as one of the Social Innovation Business, and has extensive expertise in healthcare total solutions which include medical diagnostic and clinical devices such as CT, MRI, particle beam therapy systems, and also informatics including medical service and platform. Redlen is a leading manufacturer of high resolution Cadmium Zinc Telluride (CZT) semiconductor radiation detectors which are used in the fields of medical imaging, security and nondestructive testing.
Author: Redlen Technologies
In the news
Yaletown Partners, the first institutional investor in Tasktop, wishes to congratulate Mik Kersten, CEO and Founder, and the entir…
April 8, 2021
We congratulate Sokanu (“So can you”), a Yaletown portfolio company, on its sale of its CareerExplorer platform to Penn Foster, a…
March 19, 2021